Newleos Therapeutics Announces Poster Presentation to be Featured at the 2025 World Congress of Biological Psychiatry September 11, 2025
Newleos Therapeutics Announces Poster Presentation to beFeatured at the 2025 World Congress of BiologicalPsychiatry September 9, 2025
Newleos Therapeutics Appoints Stephen Brannan to Board of Directors and Announces NTX-1955 Clinical Progress in Generalized Anxiety Disorder July 24, 2025
Newleos Therapeutics Announces Clinical Advisory Board to Support Key Neuropsychiatry Programs April 29, 2025
